Final results from C3BS-CQR-1 Phase II trial on heart failure News-Medical.net André Terzic, MD, Ph.D, Director at Center of Regenerative Medicine, Mayo Clinic, the co-lead investigator on the trial, will present new final follow up data on the Company's stem cell therapy for heart failure, C3BS-CQR-1, which is based on ... |
